The Potential of Personalized Sleep Therapies

About the episode:

In this episode, psychiatrist and sleep expert Dr. Andrew Krystal unveils the latest advancements in personalized sleep therapies, guiding listeners through leading-edge interventions transforming insomnia treatment. He examines the shift from traditional benzodiazepines to targeted approaches like histamine antagonists and dual orexin receptor antagonists (DORAs). Dr. Krystal highlights how customized pharmacotherapy improves patient care and outcomes, addressing the complex interplay between sleep and psychiatric disorders. This episode offers crucial insights into the evolving landscape of sleep medicine and the potential of precision treatments.

About the series:

Atria’s Vanguard Symposia is a lecture series where some of the world’s most compelling researchers translate leading-edge science into medicine. In each episode, top experts share breakthrough science about preventive health care, dive deep into headline-grabbing topics, and take you beyond the buzzwords to explain the latest in longevity science. Our show will arm you with practical information and the tools of discernment to cut through the hype and understand what matters most.

Atria Health and Research Institute aims to accelerate a global shift from reactive sick care to proactive, preventive health care. We work at the forefront of science and technology and we believe a collaborative approach to modern medicine can extend healthy life for all.